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Abstract
Background: Increasing cervical screening coverage by reaching inadequately screened groups is essential for
improving the effectiveness of cervical screening programs. Offering HPV self-sampling to women who are never or
under-screened can improve screening participation, however participation varies widely between settings.
Information on women’s experience with self-sampling and preferences for future self-sampling screening is
essential for programs to optimize participation.
Methods: The survey was conducted as part of a larger trial (“iPap”) investigating the effect of HPV self-sampling on
participation of never and under-screened women in Victoria, Australia. Questionnaires were mailed to a) most
women who participated in the self-sampling to document their experience with and preference for self-sampling
in future, and b) a sample of the women who did not participate asking reasons for non-participation and
suggestions for enabling participation. Reasons for not having a previous Pap test were also explored.
Results: About half the women who collected a self sample for the iPap trial returned the subsequent
questionnaire (746/1521). Common reasons for not having cervical screening were that having Pap test performed
by a doctor was embarrassing (18 %), not having the time (14 %), or that a Pap test was painful and uncomfortable
(11 %). Most (94 %) found the home-based self-sampling less embarrassing, less uncomfortable (90 %) and more
convenient (98 %) compared with their last Pap test experience (if they had one); however, many were unsure
about the test accuracy (57 %). Women who self-sampled thought the instructions were clear (98 %), it was easy to
use the swab (95 %), and were generally confident that they did the test correctly (81 %). Most preferred to take
the self-sample at home in the future (88 %) because it was simple and did not require a doctor’s appointment.
Few women (126/1946, 7 %) who did not return a self-sample in the iPap trial returned the questionnaire. Their
main reason for not screening was having had a hysterectomy.
Conclusions: Home-based self-sampling can overcome emotional and practical barriers to Pap test and increase
participation in cervical screening despite some women’s concerns about test accuracy. Mailing to eligible women
and assuring women about test accuracy could further optimize participation in screening.
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Background
Increasing coverage by reaching women who are not
screened or under-screened is essential for improving
the effectiveness of cervical screening programs [1].
This is because most cancers in an organised screen-
ing program are diagnosed in women who have never
been screened or are lapsed screeners [2]. Several
strategies have been tried to improve screening par-
ticipation, of which reminder letters have been shown
to have a modest effect [3]. Nevertheless, barriers to
having a Pap test remain.
Recently, it has been shown that human papillomavi-
rus (HPV) testing as a primary screening test is more
sensitive than a Pap test and provides better protection
against cervical cancer [4]. Primary HPV testing also al-
lows for self-sampling; a self-collected sample has been
shown to have similar sensitivity (for underlying high
grade cervical disease) to that of a practitioner-collected
sample when a validated PCR based test is used [5].
Self-sampling for HPV testing has been shown to be
more effective than a reminder letter to have a Pap test at
improving cervical screening participation by women who
are apparently never- and under-screened [6, 7]. However,
information about women’s overall experience i.e. from
the receipt of the self-sample pack at home to performing
the test and mailing back the sample and receiving their
results in the post is lacking. This information is essential
for planning programs moving to primary HPV screening
where self-sampling might be an option for women who
do not attend cytological screening.
Prior to the start of a trial of home delivered HPV self-
sample kits, we conducted four focus groups, including
never- and under-screened women aged 30–69 years [8].
In the focus groups, women were positive towards the
idea of self-sampling but expressed concerns about test
accuracy and were not confident that the self-sampling
would give the same results as a practitioner administered
test [8]. However, women in the focus groups were only
shown the device (dry flocked swab) and opinions were
based on perceptions rather than experience. Few studies
have reported on women’s actual experience with self-
sampling, their preferences for cervical screening in the
future, and the rationale behind these preferences espe-
cially among non-attendees of a screening program who
have taken up an offer of self-sampling [9–12]. Only two
studies have reported reasons for declining self-sampling
among non-attendees of routine screening [9, 10].
This paper reports on a survey of never- and under-
screened women who were randomised in a trial of self-
sampling in Victoria, Australia, to document their
experience with home-based HPV self-sampling and their
views about self-sampling for cervical screening in future.
Additionally, we investigated women’s reasons for not pre-
viously having had a Pap test, or an up-to-date one.
Methods
Australia’s National Cervical Screening Program was in-
troduced in 1991. Current policy recommends that sexu-
ally active women should be screened every 2 years with
Pap tests, beginning at age 18 years (or 2 years after onset
of sexual activity, whichever is later) until 69 years [13].
Pap testing is primarily provided through general practice
and other primary healthcare settings with up to 85 % re-
bates available from Medicare (Australia’s publicly funded
universal health care system) [14]. Eight jurisdictional cer-
vical registries (Pap test registries) underpin the Program
by (i) sending reminder letters, (ii) providing a safety net
for follow-up of women with abnormal Pap smears, (iii)
providing laboratories with screening histories to help
with accurate reporting of tests and (iv) providing labora-
tories with quantitative data to assist with quality assur-
ance [13]. The Victorian Cervical Cytology Registry
(VCCR) is one of the jurisdictional registers and operates
under the Victorian Cancer Act. The VCCR records de-
tails of almost all Pap tests performed in Victoria (<1 %
opt-off). It also records details of hysterectomy, where
these are provided by the woman or her practitioner. Par-
ticipation in cervical screening in Victoria for 2 year
(2012–2013) and 3 year (2011–2013) periods was 60.4
and 72.7 % respectively [2]. In 2017, Australia will be mov-
ing to five yearly primary HPV testing commencing at age
25, where self-sampling will be made available through
medical or nurse practitioners (who will offer main stream
cervical screening), in clinics, to women who are never- or
under-screened, as per the revised policy, and who do not
want to undergo a gynaecological examination [14].
The survey was conducted as a part of the iPap trial, a
randomized controlled trial of home-based HPV self-
sampling for improving participation in cervical screening
by apparently never- and under-screened women [15].
Apparently never-screened women were women who
were in the Victorian Electoral Roll and for whom no
match was found in the VCCR indicating that no cervical
screening episode had ever been recorded for these
women (the two databases were matched on name, ad-
dress and date of birth). Under-screened women were
women whose last Pap test record in the VCCR was be-
tween 5 and 15 years ago. Women were eligible for the
trial if they were 30–69 years, resided in Victoria, never-
screened or under-screened, had not had a hysterectomy,
and were not pregnant at the time of the study. No infor-
mation on eligibility (other than age) was available for
never-screened women prior to randomisation as by def-
inition these women did not exist in the register that re-
cords details of screening history and hysterectomy. A
total of 16,320 women were randomly allocated to either
receive a) a pre-invitation letter followed a few weeks later
by an HPV self-sampling kit (n = 14,280), or b) just a re-
minder letter to attend for a Pap test (n = 2040) in a 7:1
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randomization ratio, and stratified by screening history
(never- and under-screened). The self-sampling device
was a nylon tipped flocked swab (Copan Italia, Brescia,
Italy) enclosed in a dry plastic tube. A written and pictor-
ial instruction sheet was enclosed detailing sample collec-
tion and postage. The mailout took place in 34 batches
between March and July 2014. A kit was not mailed if the
women opted out or reported ineligibility e.g. hysterec-
tomy, recent Pap test, pregnancy, migration, death,
disability, gender issues. A kit was also not mailed if the
letter was returned to sender (Fig. 1). The primary out-
come of the trial was return of a completed HPV self-
sampling kit or the notification of a Pap test result to the
VCCR measured at 3 and 6 months after the mailout of
pre-invitation letter. The details of the trial design are
described elsewhere [15].
A total of 1649 women returned a self-sample within
6 months of the mail out of the letters. Of these 1521
(92.2 %) were mailed a questionnaire after they were sent
their results letters. We also sent questionnaires to 1946/
12,010 women in the self-sampling arm (i.e. in the first
seven of 34 batches) who did not return a self-sample or
have a Pap test and whose letter did not come back return
to sender or who did not report a hysterectomy, recent
Pap test or pregnancy (Fig. 1). Time and resources allo-
cated to the trial did not permit us to mail to all women
in the self-sampling arm of the trial; especially the group
that did not return a self-sample nor had a Pap test. We
therefore used a sample of all participants and the most
efficient way to achieve this was to use the women in the
first batches of the trial. Given that the batches were ran-
domly ordered, non-respondents in the first seven batches
should be similar to those in the rest of the trial. The
questionnaires were completed anonymously. The Human
Research Ethics Committee of the Victorian Department
of Health approved the study. Informed consent was
waived for the main trial and the survey was conducted as
a part of this trial. However, a cover letter explaining the
purpose of the questionnaire and its anonymity was
mailed to women in the survey.
Different questionnaires were designed for women
who returned a self-sample and those who did not
(Additional file 1). Those who returned a self-sample
were asked about their experience with self-sampling,
their willingness to participate in future self-sampling
and their preference for collection at home or clinic.
Women who did not return a self-sample were asked
about reasons for not attending regular cervical
screening, for not returning the kit, and what things
would have helped them do so. Common to both ques-
tionnaires were questions on age, postcode of residence,
screening history and reasons for never/not having had a
recent Pap test. Age was reported in 10-year age categor-
ies (30–39, 40–49, 50–59 and 60+ years) and socioeco-
nomic status (SES) as quintiles (1 being the lowest and 5
being the highest). SES is an area level variable assigned to
women based on the 2011 Socio-economic Index of Areas
(SEIFA), a composite measure of relative socio-economic
disadvantage, as determined from their postcode of resi-
dence [16]. Screening history was classified as no history
of having a Pap test, had a Pap test within last 5 years,
≥5 years since last Pap test or unsure of the time since last
Pap test as self-reported by women. The questionnaires
were completed anonymously and so could not be linked
Fig. 1 Participants in the iPap trial and questionnaires mailed and returned
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to the Victorian Pap test Register or any other data. We
verified the self-reported Pap test done in Victoria for the
main trial, which revealed that the reporting was reliable if
the woman was never-screened (i.e. reported no Pap test)
or if the last Pap test was in the recent past (data unpub-
lished). However, it is possible that some may underesti-
mate the time elapsed since their last Pap test, especially if
the Pap test was in the distant past. We were also unable
to verify self-reported Pap tests done interstate or overseas
as this is beyond the scope of the current registers.
Women were asked to give one main reason (single re-
sponse) and up to three other reasons (multiple responses)
for never/not having had a Pap test from a list of options,
developed from previous research in Victoria on reasons
for not screening (Additional file 1) [8, 17]. The main rea-
son for not having a Pap test was also explored by self-
reported screening status (i.e. never-screened, screened
within 5 years and under-screened) in the group that
returned both the self-sample and the questionnaire. We
do not report the socio-demographic characteristics of
women who did not return a self-sample in the iPap trial
but returned a questionnaire given the very low response
rate in this group (7 %). All the questions were close-
ended questions. At the end of each questionnaire there
was an option for open answer/comments where women
were asked to make general comments about self-
sampling (Additional file 1). Percentages were calculated
for each answer and presented accordingly. Open answers
or quotes are used to illustrate a survey finding where a
need for better understanding was required. All data were
analysed using Stata version 11.1 (StataCorp, College Sta-
tion, TX).
Results
Response rate and socio-demographic characteristics
A total of 3468 questionnaires were mailed: 1521 to
women who returned a self-sample as part of the
iPap trial and 1946 to women who neither returned a
self-sample nor had a subsequent Pap test. Question-
naires were returned by 746 (49 %) and 126 (7 %)
women respectively.
Table 1 compares the socio-demographic character-
istic of questionnaire responders and non-responders
among the 1521 women who returned a self-sample
and who were mailed a questionnaire. Questionnaire
responders were more likely to be older (p = 0.002),
from higher SES (p < 0.001) and screened within
5 years (p < 0.001). The median age (interquartile
range) of women who did not return a self-sample
but returned a questionnaire was 56 (44–64) years;
21 % reported they were never-screened, 39 % under-
screened, 31 % screened within 5 years and 9 % un-
sure about screening history (data not shown).
Experience of self-sampling participants
Reasons for not having a Pap test
Overall, 553 (74 %) women provided one main reason
for not having a Pap test (Table 2), and the most
common reason was embarrassment about having the
test performed by a doctor (18 %). The most com-
mon reason that never-screened women had not had
a Pap test was that they had never had sex (24 %);
followed by believing that having the test performed
by a doctor would be embarrassing (19 %). For the
under-screened women, the most common reason
was embarrassment at having a Pap test (16 %),
followed by it being hard to find time (15 %).
Experience with HPV self-sampling
Of the 746 who did the self-sampling and returned a
questionnaire, 737 (99 %) provided a response to at
least one of the statements related to the experience
(Table 3). The process of doing the test was rated
Table 1 Demographic characteristic of questionnaire
responders and non-responders among those that returned a
self-sample and were mailed a questionnaire











Age (years) N n % row n % row
30–39 429 177 41.3 252 58.7 0.002
40–49 350 175 50.0 175 50.0
50–59 331 165 50.0 166 50.0
60+ 411 223 54.3 188 45.7
SESc
1 (lowest) 334 105 31.4 229 68.6 <0.001
2 286 119 41.6 167 58.4
3 327 124 37.9 203 62.1
4 301 188 62.5 113 37.5
5 (highest) 273 199 72.9 74 27.1
Screening historyb
No Pap test 409 163 40.0 246 60.0 <0.001
Yes,
<5 years
256 229 89.5 27 10.5
Yes,
≥5 years
809 344 42.5 465 57.5
Unsure/
Don’t know
47 5 10.6 42 89.4
aTotal women in the iPap trial who returned a self-sample and who were
mailed a questionnaire (n = 1521)
bSelf-reported screening history
cSES is an area level variable assigned to women based on the 2011
Socio-economic Index of Areas (SEIFA)
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Table 2 Main reason and other reasons for not having had a Pap test
Reasons Returned a self-sample and a questionnaire (n = 746)d Returned a questionnaire but not a self-sample (n = 126)e





(n = 126)cOverall Never-screened Screened <5 years Under-screened
(n = 553)a (n = 144) (n = 122) (n = 281) (n = 746)c
n % n % n % n % n % n % n %
1. I don’t think I need a Pap test 43 7.8 20 13.9 4 3.3 19 6.8 85 11.4 4 4.4 15 11.9
2. I don’t know if or when I should have a Pap test 19 3.4 10 6.9 7 5.7 2 0.7 57 7.6 2 2.2 4 3.2
3. I am not having sex 33 6.0 17 11.8 5 4.1 11 3.9 94 12.6 4 4.4 12 9.5
4. I have never had sex 39 7.1 35 24.3 1 0.8 3 1.1 25 3.4 11 11.9 2 1.6
5. I have had a hysterectomy 39 7.1 3 2.1 3 2.5 32 11.4 28 3.8 40 43.5 2 1.6
6. A Pap test from a doctor
is embarrassing
97 17.5 28 19.4 23 18.9 45 16.0 167 22.4 5 5.4 16 12.7
7. A Pap test from a doctor
is painful or uncomfortable
58 10.5 10 6.9 13 10.7 34 12.1 111 14.9 5 5.4 7 5.6
8. I have had a bad experience in
the past having a Pap test
32 5.8 0 0 4 3.3 26 9.3 71 9.5 1 1.1 4 3.2
9. I don’t feel comfortable asking
for a Pap test from my doctor
25 4.5 8 5.6 4 3.3 12 4.3 125 16.7 2 2.2 4 3.2
10. My doctor has not suggested a Pap test 21 3.8 4 2.8 2 1.6 15 5.3 97 13.0 1 1.1 13 10.3
11. It is hard to find the time to have a Pap test 75 13.6 3 2.1 30 24.6 42 14.9 93 12.5 9 9.8 8 6.4
12. It is hard to find the right doctor
or get an appointment
33 6.0 2 1.4 11 9.0 20 7.1 102 13.7 3 3.3 4 3.2
13. It is hard to travel to an appointment 6 1.1 0 0 1 0.8 5 1.8 32 4.3 1 1.1 1 0.8
14. It is too expensive to have a Pap test 5 1.0 0 0 1 0.8 4 1.4 25 3.4 0 0 0 0
15. I have not received a reminder letter
to have a Pap test
27 4.9 4 2.8 13 10.7 10 3.6 73 9.8 3 3.3 5 4.0
16. I don’t think Pap test results are accurate enough 1 0.2 0 0 0 0 1 0.4 15 2.0 1 1.1 1 0.8
aThe overall includes never-screened (n = 144), under-screened (n = 281), screened in the last 5 years (n = 122) and unsure/don’t know (n = 6)
bSingle response question where women were asked to give one main reason
cMultiple response question where women were asked to give up to three other reasons
dOf the 746 women who returned a self-sample and a questionnaire, 131 (17.5 %) did not provide a main reason and 62 (8.3 %) provided more than one main reason that was included with the other reasons as we
were unable to determine the main reason
eOf the 126 women who did not return a self-sample but returned a questionnaire, 31 (24.6 %) did not provide a main reason and 3 (2.4 %) provided more than one main reason that was included with the other











very highly, with almost all women saying the instruc-
tions were very clear (98 %) and most finding the
swab easy to use (95 %), especially those who had
had a Pap test in the past (96 % versus 91 %).
Women’s confidence in performing the test was also
high, with 81 % very confident that they did it cor-
rectly, more so for the ever-screened (83 % versus
77 %). The test was also perceived to be very con-
venient (91 %). The majority also found self-sampling
was not embarrassing (92 %) or painful (82 %). How-
ever, a quarter found it a little uncomfortable and
15 % reported it to be a little painful. When stratified
by screening history, there were more never-screened
than ever screened women who felt a little pain
(19 % versus 14 %), were a little uncomfortable (35 %
versus 22 %) and a little embarrassed doing the self-
sample (12 % versus 4 %).
The following were typical comments:
“Having not had a Pap test before, I was grateful for
the kit being sent out. It wasn’t invasive and put my
mind at ease having good results.”
“What a fabulous development – quick, easy, free,
non-embarrassing and no appointment required.
Results posted to one’s house. Hope this continues and
more medical tests like this are developed in the
future.”
When the 573 women who had previously had a Pap
test were asked to compare that experience with self-
sampling, most women found self-sampling easier
(93 %), more convenient (98 %), less embarrassing
(94 %) and less uncomfortable (90 %). However, when
asked about accuracy, 57 % were unsure which was bet-
ter and another 20 % thought there was no difference
between the two methods (Table 4).
The following were typical comments:
“This was very quick and easy to do. Much better than
having to make an appointment then wait in a
waiting room for up to an hour to see a doctor for the
simple task.”
“The convenience, efficient use of time, privacy and
comfort of the self-sampling has got me interested
again in having a regular pap test.”
“Got positive result from self sample, had to go to a
doctor, recheck, she got normal results & charged me”
Table 3 Experience with self-sampling among those that returned a self-sample and a questionnaire
Experience with self-sampling (row %) n =
746
Not at all A little Very much Unsure
n % n % n % n %
1. I thought the instructions were clear 737 4 0.5 10 1.4 721 98.0 2 0.3
Never-screened 162 2 1.2 1 0.6 158 97.5 1 0.6
Ever-screened 575 2 0.4 9 1.6 563 97.9 1 0.2
2. It was easy to use the swab 728 8 1.1 32 4.4 688 94.5 0 0
Never-screened 162 4 2.5 11 6.8 147 90.7 0 0
Ever-screened 566 4 0.7 21 3.7 541 95.5 0 0
3. Taking the sample with the swab was painful 715 585 81.8 108 15.1 19 2.7 3 0.4
Never-screened 159 122 76.7 30 18.9 5 3.1 2 1.3
Ever-screened 556 463 83.3 78 14.0 14 2.5 1 0.2
4. Taking the sample with the swab was uncomfortable to do 714 514 72.0 180 25.2 20 2.8 0 0
Never-screened 158 99 62.7 56 35.4 3 1.9 0 0
Ever-screened 556 415 74.6 124 22.3 17 3.1 0 0
5. I felt embarrassed 708 650 91.8 39 5.5 17 2.4 2 0.3
Never-screened 155 130 83.9 19 12.3 5 3.2 1 0.7
Ever-screened 553 520 94.0 20 3.6 12 2.2 1 0.2
6. It was convenient 729 48 6.6 17 2.3 664 91.1 0 0
Never-screened 162 11 6.8 4 2.5 147 90.7 0 0
Ever-screened 567 37 6.5 13 2.3 517 91.2 0 0
7. I am confident I did it correctly 728 29 3.9 81 11.1 592 81.3 26 3.4
Never-screened 161 7 4.4 24 14.9 124 77.0 6 3.7
Ever-screened 567 22 3.9 57 10.1 468 82.5 20 3.5
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Preference for self-sampling in future
Women who did self-sampling were asked if they would
prefer to see a health professional or take their own
sample for cervical screening in future: 734 out of 746
(98 %) reported a preference; of those, 88 % (n = 644)
preferred to take their own sample at home, 1.2 % (n =
9) preferred to take their sample at a medical clinic, 6 %
(n = 42) preferred a health professional to take their
sample and 4 % (n = 27) were not sure. A few women
also reported that they did not intend to screen again (n
= 12, 1.6 %). Of those that preferred to take their own
sample (n = 653), either at home or a clinic, the top two
reasons for their preference was that the self-sample test
was simple to do (59 %) and did not require an appoint-
ment with a doctor (55 %).
The following were typical comments:
“I felt very comfortable with the self sample test. And
would like to do my own test from home from now on”
“loved it, would do it regularly if I can do it myself.
Best idea ever!!! and it was free!
“…I would even pay more than a doctor’s visit if it was
an option to purchase these kits”
Non-participants to the offer of self-sampling
Reasons for not-returning a self-sample and intention to
screen
We asked women who did not return a self-sample
or who did not have a subsequent Pap test what they
did with the kit (Table 5). Of the 126 who did not
screen but returned a questionnaire, 111 (88 %) re-
membered receiving the kit in the mail. Of the 111
women, 16 (14 %) had not opened the kit, 66 (60 %)
had opened the kit but did not self-sample, another
16 (14 %) had opened it and threw it away and 8
(7 %) threw it away unopened, 3 (3 %) completed it
but not returned it and 2 (2 %) had completed and
returned it.
We also asked women about their intention to
complete and return the kit. Of the 111 women, 70 %
(n = 78) reported that they had no intention to
complete and return the kit, 17 % (n = 19) still intended
to complete and return the kit and another 13 % (n =
14) were unsure. The main reasons for not doing the
self-sample test were that women thought they did not
need it because they have had a hysterectomy (42 %),
17 % believed that only health professionals should do
this sort of test, 10 % were not sexually active, and 6 %
did not think it is as reliable as a Pap test. Hysterec-
tomy (44 %) and never having had sex (12 %) were also
the two main reasons, reported by women who did not
return the self-sample, for not attending regular screen-
ing (Table 2). Of those who still intend to complete and
return the test, the two main reasons for not having
done it yet were that 63 % forgot about the kit or had
not got around to it, 21 % were too busy and another
10 % thought it looked like it could be painful/uncom-
fortable and 5 % were worried about the test results.
Women who were unsure (n = 14) were also asked to
report two things that would enable them to make a de-
cision regarding whether to do the test or not. Talking
to their doctor (n = 7) or getting more information on
the test (n = 5) or being sure that it was as reliable as a
Pap test (n = 3) were some of the things that women re-
ported would help them make a decision regarding
doing the test. Other suggestions to enable decision
making, were seeing a demonstration video in the
website (n = 1) or talking to someone who has done the
test (n = 1).
The following were typical comments:
“No, I prefer to get advice by a doctor who has
experience about pap testing, that's why I didn't
complete the self kit Pap test sample.”
“I also felt I wasn’t qualified to do this and wasn’t sure
if able to do it correctly.”
Table 4 Comparing self-sample taken at home to the last Pap
test performed by a doctor







n % n % n % n %
Easier 525 490 93.3 11 2.1 20 3.8 4 0.8
More convenient 519 507 97.7 3 0.6 4 0.8 5 1.0
Less embarrassing 507 478 94.3 2 0.4 24 4.7 3 0.6
Less uncomfortable 494 446 90.3 12 2.4 34 6.9 2 0.4
More accurate 469 67 14.3 40 8.5 93 19.8 269 57.4
Table 5 Intention to complete the test if women have not
returned the self-sample
What have you
done with the kit?
Total Intention to complete







I have opened it but
not done it
66 59.5 44 (66.7) 10 (15.2) 12 (18.2)
I haven’t opened it 16 14.4 10 (62.5) 4 (25.0) 2 (12.5)
I have opened it,
but threw it away
16 14.4 16 (100) 0 0
I threw it away unopened 8 7.2 8 (100) 0 0
I have completed it
but not returned it
3 2.7 0 0 3 (100)
I have completed
and returned it
2 1.8 0 0 2 (100)
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“It reminded me to ask my new doctor for a pap test.
Thanks! I think it is a good idea for those who don’t
have good access to a doctor, or who can’t afford to
have a pap test.”
Discussion
Key findings
Overall, common reasons for not having a Pap test were
related to embarrassment, not having time, or that a Pap
test was painful and uncomfortable. Participants found
the home-based self-sampling less embarrassing and less
uncomfortable compared with their last Pap test experi-
ence. Women who self-sampled thought the instructions
were clear and were generally confident that they did
the test correctly; however, many were unsure about the
test accuracy. The majority preferred to take their own
sample at home if offered in future because it was simple
and did not require an appointment with a doctor.
Reasons for not participating in regular screening
The main reason for not participating in regular screen-
ing provided by women who participated in iPap trial
was emotional/attitudinal i.e. Pap test from a doctor is
embarrassing (18 %), with the second most common
reason being related to practical issues such as finding
time to do a Pap test (14 %). This was similar to the
findings in the UK trial for non-attendees where emo-
tional barriers (uncomfortable/painful/unpleasant etc.)
were more common than practical barriers (lack of
time/busy/no childcare etc.) [18] but unlike that in a
Dutch study where the main reason for non-attendance
was that women forgot to schedule an appointment
(32.3 %) [10]. In an Italian study, the main reason for
failing to comply with a previous screening invitation
was a recent Pap smear done outside the screening pro-
gram (40.6 %) with the second most common reason be-
ing related to practical issues such as no time (23 %)
[11]. In another population based survey in England,
practical barriers were more predictive of screening up-
take than emotional barriers [19]. No previous studies
have reported barriers by screening status (never- and
under-screened). In our survey, the main reason pro-
vided by never-screened women, who participated in
self-sampling, for not having a Pap test was that they
had never had sex. In Australia, only women who have
ever been sexually active are actively encouraged to par-
ticipate in screening.
Self-sampling can overcome main barriers to cervical
screening
Women found self-sampling more convenient, less
embarrassing, less uncomfortable and less painful than
their last Pap test. This is encouraging as self-sampling is
likely to overcome the two main barriers reported by
women in this study (related to test and time). The experi-
ence was similar for never- and ever-screened except that
more never-screened women reported a little more pain,
discomfort and embarrassment than ever-screeners.
Nevertheless, 88 % of the self-sampling participants pre-
ferred to take their own sample at home in future and this
was because it was simple to do and did not require a doc-
tor’s appointment. Similar reasons were also reported in
other studies that included non-attendees of regular
screening who took up self-sampling [9–12, 20].
Improving participation using self-sampling
One of the issues regarding self-sampling identified in
our focus group and in other studies was concern about
test accuracy [8]. While the majority of women who did
the self-sampling in our trial reported that they were
confident about doing it correctly (81 %), only 14 %
thought it was more accurate than a Pap test performed
by a doctor. These findings about confidence are in line
with the results of a large trial among non-attendees in
The Netherlands (n = 30,130) which compared a lavage
with a brush self-sampling device. In this study, 20 % of
all participants reported that they were concerned about
taking the self-sample correctly with no difference be-
tween the two groups [12]. In another study among
non-attendees of a cervical screening program who par-
ticipated in self-sampling in Finland, around 88 % felt
confident that they collected the sample successfully
using a lavage-like device and a similar proportion
(83 %) trusted the test results [9]. It is difficult to pin-
point if the difference between our study and the study
in Finland related to trust in the self-sampling test is
due to the different devices used in the two studies, the
way the information was communicated, or the extent of
details covered. Moreover, in the Finland study, around
22 % of the participants also reported that they felt inse-
cure during the sample taking and commonly reported
concerns related to the plunger of the device not releas-
ing properly, fluid leaking out during sample taking and
the small volume of the sample collected using device
indicating that a certain level of doubt will remain [9].
Furthermore, 13 % (14/111) of women who did not do
the self-sampling but returned a questionnaire reported
they were unsure about their intention to do the test.
These women said that talking to a doctor, or getting
more information on the test and being sure that the
home-based test was as reliable as a Pap test would as-
sist their decision-making. Another 20 % (19/111) who
did not return the self-sample still intended to do the
test and the questionnaire acted as a reminder for them.
This is an indication that there will be some women
who will not prioritize screening even after being mailed
a kit and a further reminder might trigger their partici-
pation; this was evident in a trial of home-based self-
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sampling in Sweden where high participation (39 %) was
achieved for under-screened women when a reminder
letter was sent if the kit was not returned in time [20].
The very low questionnaire response rate (7 %) by
women who did not return a self-sample limits the val-
idity of the results of our study for this group. These
women were non-responders to participation in the
main trial so a low rate of response to the survey was
not unexpected. These women mostly used the ques-
tionnaire to report their hysterectomy status, which was
also the main reason for not screening previously. This
was different from findings in the Finnish study where a
recent Pap test elsewhere was the main reason provided
by the majority (70 %) who did not take part in the self-
sampling but returned a questionnaire (10 % response
rate) [9] reflecting differences in the target population to
our study. In another study in The Netherlands, only
2.3 % of those who did not self-sample but returned a
questionnaire reported that they preferred an invitation
for regular screening [10]. In our study, no information
on eligibility was available for never-screened women
prior to randomisation given that these women did not
have records in the register regarding details of prior
Pap tests or hysterectomy status. However, when self-
sampling is possibly made available in the revised
National Cervical Screening Program of Australia (with
a move to primary HPV testing in May 2017), through
medical or nurse practitioners, in clinics, the issue of eli-
gibility may be resolved through direct conversation with
the woman about her previous medical history and rea-
sons for not screening previously or delaying screening.
With home-based self-sampling, the issue of eligibility
needs to be clearly communicated in the materials sent
with the kit.
Strengths and limitations
Resource and time constraints did not permit us to mail
to all women in the self-sampling arm of the trial for
feedback about their experience. Of those mailed, the re-
sponse to questionnaires by those who screened using
self-sampling was modest and those who were long term
non-attenders and from lower socioeconomic back-
grounds are underrepresented. This is one of the few
studies to report on self-sampling experience of never-
and ever-screened women who did not attend regular
screening but who took up the offer of self-sampling and
key areas to focus on to optimise this as a strategy for
improving coverage. A major limitation of our study is
the very low response rate of the women who did not re-
turn a self-sample. Non-responders are a hard group to
reach in any screening program and little is known
about their reasons for non-participation and things that
would encourage them to participate. Although a small
and potentially biased group, the study provides some
insight into their information needs and what would en-
able them to participate.
Conclusion
In conclusion, home based self-sampling can overcome
emotional/attitudinal and practical barriers to Pap testing
and increase participation in cervical screening because
women view it as less embarrassing, less uncomfortable,
more convenient and easier than having a Pap test. These
findings are encouraging considering women would not
have heard of self-sampling testing for HPV outside this
trial. Although many women were unsure about the test
accuracy, they still preferred to self-sample in future as it
was simple and did not require an appointment. Among
those that did not perform the self-sample, some were un-
sure and decision-making was dependent on getting more
information or being sure that the test was reliable. There-
fore to optimize this intervention as a strategy and to im-
prove participation, provision of clear information and
education around test accuracy of self-sampling, as well as
clear instructions about how to take the sample, to both
the providers and their clients will be very important. In-
formation on eligibility will also have to be clearly com-
municated if kits are to be mailed home for self-sampling.
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